Cargando…
PB2344: RESILIENCE IN PATIENTS WITH LYMPHOID MALIGNANCIES: THE REPLY STUDY.
| Autores principales: | , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429020/ http://dx.doi.org/10.1097/01.HS9.0000852200.89409.70 |
| _version_ | 1784779302132252672 |
|---|---|
| author | Dos Santos, G. Bogliacino, V. Irigoin, V. Toledo, V. Oldan, P. Blanco, K. Specht, P. Montaño, A. Posada, M. Alpire, I. Garrido, D. Alpuin, A. Villalvir, D. Guillermo, C. |
| author_facet | Dos Santos, G. Bogliacino, V. Irigoin, V. Toledo, V. Oldan, P. Blanco, K. Specht, P. Montaño, A. Posada, M. Alpire, I. Garrido, D. Alpuin, A. Villalvir, D. Guillermo, C. |
| author_sort | Dos Santos, G. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9429020 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94290202022-08-31 PB2344: RESILIENCE IN PATIENTS WITH LYMPHOID MALIGNANCIES: THE REPLY STUDY. Dos Santos, G. Bogliacino, V. Irigoin, V. Toledo, V. Oldan, P. Blanco, K. Specht, P. Montaño, A. Posada, M. Alpire, I. Garrido, D. Alpuin, A. Villalvir, D. Guillermo, C. Hemasphere Publication Only Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9429020/ http://dx.doi.org/10.1097/01.HS9.0000852200.89409.70 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Publication Only Dos Santos, G. Bogliacino, V. Irigoin, V. Toledo, V. Oldan, P. Blanco, K. Specht, P. Montaño, A. Posada, M. Alpire, I. Garrido, D. Alpuin, A. Villalvir, D. Guillermo, C. PB2344: RESILIENCE IN PATIENTS WITH LYMPHOID MALIGNANCIES: THE REPLY STUDY. |
| title | PB2344: RESILIENCE IN PATIENTS WITH LYMPHOID MALIGNANCIES: THE REPLY STUDY. |
| title_full | PB2344: RESILIENCE IN PATIENTS WITH LYMPHOID MALIGNANCIES: THE REPLY STUDY. |
| title_fullStr | PB2344: RESILIENCE IN PATIENTS WITH LYMPHOID MALIGNANCIES: THE REPLY STUDY. |
| title_full_unstemmed | PB2344: RESILIENCE IN PATIENTS WITH LYMPHOID MALIGNANCIES: THE REPLY STUDY. |
| title_short | PB2344: RESILIENCE IN PATIENTS WITH LYMPHOID MALIGNANCIES: THE REPLY STUDY. |
| title_sort | pb2344: resilience in patients with lymphoid malignancies: the reply study. |
| topic | Publication Only |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429020/ http://dx.doi.org/10.1097/01.HS9.0000852200.89409.70 |
| work_keys_str_mv | AT dossantosg pb2344resilienceinpatientswithlymphoidmalignanciesthereplystudy AT bogliacinov pb2344resilienceinpatientswithlymphoidmalignanciesthereplystudy AT irigoinv pb2344resilienceinpatientswithlymphoidmalignanciesthereplystudy AT toledov pb2344resilienceinpatientswithlymphoidmalignanciesthereplystudy AT oldanp pb2344resilienceinpatientswithlymphoidmalignanciesthereplystudy AT blancok pb2344resilienceinpatientswithlymphoidmalignanciesthereplystudy AT spechtp pb2344resilienceinpatientswithlymphoidmalignanciesthereplystudy AT montanoa pb2344resilienceinpatientswithlymphoidmalignanciesthereplystudy AT posadam pb2344resilienceinpatientswithlymphoidmalignanciesthereplystudy AT alpirei pb2344resilienceinpatientswithlymphoidmalignanciesthereplystudy AT garridod pb2344resilienceinpatientswithlymphoidmalignanciesthereplystudy AT alpuina pb2344resilienceinpatientswithlymphoidmalignanciesthereplystudy AT villalvird pb2344resilienceinpatientswithlymphoidmalignanciesthereplystudy AT guillermoc pb2344resilienceinpatientswithlymphoidmalignanciesthereplystudy |